Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel D'haeseleer

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Journal of Clinical Medicine|March 11, 2023
Advances in Neurodegenerative DiseasesJeroen Van Schependom, Miguel D'haeseleer
Frontiers in Immunology|July 31, 2023
Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer's disease and multiple sclerosis: a systematic reviewJoke Temmerman, Sebastiaan Engelborghs, Maria Bjerke, et al.
The Lancet. Neurology|June 21, 2011
Vascular aspects of multiple sclerosisMiguel D'haeseleer, Melissa Cambron, Ludo Vanopdenbosch, et al.
Frontiers in Pharmacology|January 24, 2020
Modulation of Cytokine-Induced Astrocytic Endothelin-1 Production as a Possible New Approach to the Treatment of Multiple SclerosisStéphanie Hostenbach, Miguel D'Haeseleer, Ron Kooijman, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 22, 2020
Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosisJens Devogelaere, Marie B D'hooghe, Famke Vanderhauwaert, et al.
Progress in Neurobiology|May 3, 2016
The pathophysiological role of astrocytic endothelin-1Stéphanie Hostenbach, Miguel D'haeseleer, Ron Kooijman, et al.
Neuroscience Letters|October 17, 2013
Astrocyte loss and astrogliosis in neuroinflammatory disordersStephanie Hostenbach, Melissa Cambron, Miguel D'haeseleer, et al.
Eneurologicalsci|December 21, 2017
Definition, prevalence and predictive factors of benign multiple sclerosisTatjana Reynders, Miguel D'haeseleer, Jacques De Keyser, et al.
Translational Neurodegeneration|January 8, 2020
Correction to: Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets inJeroen Van Schependom, Kaat Guldolf, Marie Béatrice D'hooghe, et al.
Translational Neurodegeneration|December 13, 2019
Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets inJeroen Van Schependom, Kaat Guldolf, Marie Béatrice D'hooghe, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Journal of Clinical Medicine|March 11, 2023
Advances in Neurodegenerative DiseasesJeroen Van Schependom, Miguel D'haeseleer
Frontiers in Immunology|July 31, 2023
Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer's disease and multiple sclerosis: a systematic reviewJoke Temmerman, Sebastiaan Engelborghs, Maria Bjerke, et al.
The Lancet. Neurology|June 21, 2011
Vascular aspects of multiple sclerosisMiguel D'haeseleer, Melissa Cambron, Ludo Vanopdenbosch, et al.
Frontiers in Pharmacology|January 24, 2020
Modulation of Cytokine-Induced Astrocytic Endothelin-1 Production as a Possible New Approach to the Treatment of Multiple SclerosisStéphanie Hostenbach, Miguel D'Haeseleer, Ron Kooijman, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 22, 2020
Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosisJens Devogelaere, Marie B D'hooghe, Famke Vanderhauwaert, et al.
Progress in Neurobiology|May 3, 2016
The pathophysiological role of astrocytic endothelin-1Stéphanie Hostenbach, Miguel D'haeseleer, Ron Kooijman, et al.
Neuroscience Letters|October 17, 2013
Astrocyte loss and astrogliosis in neuroinflammatory disordersStephanie Hostenbach, Melissa Cambron, Miguel D'haeseleer, et al.
Eneurologicalsci|December 21, 2017
Definition, prevalence and predictive factors of benign multiple sclerosisTatjana Reynders, Miguel D'haeseleer, Jacques De Keyser, et al.
Translational Neurodegeneration|January 8, 2020
Correction to: Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets inJeroen Van Schependom, Kaat Guldolf, Marie Béatrice D'hooghe, et al.
Translational Neurodegeneration|December 13, 2019
Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets inJeroen Van Schependom, Kaat Guldolf, Marie Béatrice D'hooghe, et al.
Pageof 7